Bone Densitometer Market Size
Bone Densitometer Market size was valued at USD 295.3 million in 2022 and is projected to grow at over 4.9% CAGR from 2023 to 2032. Bone densitometry, also known as dual-energy X-ray absorptiometry (DXA or DEXA), is the most common technique used by bone densitometers. It is a medical device used to measure the density and strength of bones. It is primarily employed in the diagnosis and management of osteoporosis, a condition characterized by low bone density and increased susceptibility to fractures.

Moreover, the rising geriatric population base across the world that is highly susceptible to suffer from several bone disorders will positively influence the bone densitometer market growth. For instance, according to the United Nations (UN) Department of Economic and Social Affairs estimates, the number of individuals aged 65 years or over is anticipated to triple to reach nearly 1.5 billion by the year 2050.
Bone Densitometer Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Bone Densitometer Market Size in 2022 | USD 295.3 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 4.9% |
---|
2032 Value Projection | USD 476.3 Million |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 195 |
---|
Tables, Charts & Figures | 414 |
Segments covered | Technology, Application, End-use, and Region |
---|
Growth Drivers | - Surge in incidence of osteoporosis and vitamin D deficiency
- Technological advancements in the bone densitometry
- Increasing elderly population base worldwide
- Growing awareness of osteoporosis and its impact on bone health
|
---|
Pitfalls & Challenges | - High cost of bone densitometers
- Risks associated with bone densitometers
|
---|
Further, bone densitometers are essential tools in assessing bone health in older adults and guiding appropriate preventive measures and treatment strategies, thereby owing to the abovementioned factors the adoption rate of bone densitometer devices is on a rise. Additionally, an upsurge in the incidence of osteoporosis and vitamin D deficiency emphasizes the need for bone densitometry as a valuable tool in screening, diagnosis, and management of these conditions. By accurately assessing bone health, bone densitometers assist in risk assessment, treatment planning, and monitoring of these conditions, ultimately improving patient outcomes.
COVID-19 Impact
The COVID-19 pandemic has had a significant impact on the bone densitometer market. The virus and its treatments have been shown to harm the bone health of survivors. According to a 2022 report by the National Library of Medicine, COVID-19's long-term effects can include secondary osteoporosis. Hospitals have been actively monitoring the bone health of COVID-19 survivors during follow-up visits to detect and manage osteoporosis early on. As a result, the increase in COVID-19 cases has led to an increased demand for bone densitometers, as early detection and monitoring of bone density become more important.
Bone Densitometer Market Trends
Consistent technological advancements, including the incorporation of ultrasonic densitometers, digital detectors, and computer-assisted devices indicate ease of use, high comfort, and shortened measurement times. For instance, in January 2022, at the Dubai World Trade Centers edition of MEDLAB Middle East, Beckman Coulter showcased their newly released DxA 5000 Fit workflow-automation system.
Therefore, it is anticipated that the target market will expand as a result of all these technological developments, product launches, and collaboration initiatives. Furthermore, traditional film-based X-ray detectors have been largely replaced by digital medical X-ray detectors. These detectors capture X-ray images in a digital format, allowing for immediate image acquisition, enhanced image quality, and efficient data processing.
Bone Densitometer Market Analysis
Based on technology, the bone densitometer market is segmented into axial bone densitometry and peripheral bone densitometry. The axial bone densitometry segment witnessed the largest revenue size of USD 160.2 million in 2022 and is estimated to cross USD 264.6 million by 2032. The most used method for determining bone density in the body is dual-energy X-ray absorptiometry (DEXA). Due to its great precision, ease of use, and safety for both adults and children, this equipment is frequently used for both central and peripheral bone mineral density (BMD) scans.
Osteopenia and osteoporosis are diagnosed with the help of dual-energy x-ray absorptiometry (DEXA or DXA). Additionally, high prevalence of osteoporosis among the population base, the rising adoption rate can be linked to dual-energy x-ray absorptiometry's ability to satisfy a variety of clinical needs.

Imagine you have a bone-checking machine called a bone densitometer. It helps us find out if our bones are strong or weak, and it's especially useful for people with certain conditions. One of these conditions is osteoporosis, a condition where bones become thin and brittle. It's common in older people, and the bone densitometer can help us detect it early on and keep an eye on it. By measuring the density of your bones at places like your hip and spine, this machine can tell us how likely you are to break a bone. Another condition that the bone densitometer can help with is called osteopenia. It's like a milder form of osteoporosis, where bones are less dense but not as fragile as in osteoporosis. By catching osteopenia early, we can prevent it from turning into osteoporosis. So, as more people get osteoporosis and osteopenia, the need for bone densitometry is going to keep growing. By 2032, experts predict that it'll be a billion-dollar industry, all because it's so important for keeping our bones healthy and strong.
The bone densitometer market is segmented by end-use into hospitals, specialty centers, and others. Hospitals segment accounted for 49% of market share in 2022, due to the growing tendency of government health organizations to promote advanced diagnostic tools that provide rapid results is one of the primary factors. Hospitals are also utilising fully automated technologies that can identify this condition early in the existing setting.
Additionally, hospitals play a crucial role in the diagnosis and management of osteoporosis. Bone densitometry, particularly dual-energy X-ray absorptiometry (DXA), is the primary diagnostic tool for osteoporosis. Hospitals need bone densitometers to accurately assess bone mineral density (BMD) and evaluate fracture risk in patients. This information is vital for making treatment decisions and implementing preventive measures.
U.S. bone densitometer market size held more than USD 103.6 million in 2022, owing to different collaborative initiatives performed by various companies to increase their R&D capabilities and maintain high medical standards. The increasing use of modern technology in healthcare systems, as well as the expanding burden of chronic diseases, are driving the U.S. market growth.
Imagine thisin 2022 alone, over 3,900 people in the United States will be diagnosed with bone and joint cancer. That's about 1,750 women and 2,160 men. Cancer is one of the leading causes of weak and brittle bones. That's because cancer cells and the treatments we use to fight them can damage the cells that keep our bones strong. And guess what? The increasing number of people with bone-related problems is making a big demand for devices that can help us understand our risk of breaking bones. So, not only is cancer hurting our bones, but it's also helping to drive the growth of the medical equipment industry, especially for devices that help us spot bone problems early on, like the bone densitometer system.
Bone Densitometer Market Share
Some of the notable key companies operating in the bone densitometer market include
- GE Healthcare Hologic Inc
- DMS Imaging
- Swissray International Inc
- Xingaoyi Medical Equipment Co Ltd
- Eurotec Medical Systems Srl
- Trivitron Healthcare
- Scanflex Healthcare AB
- Medonica Co Ltd
- OsteoSys Corp
These companies are implementing various growth strategies such as collaborations, partnerships, acquisitions & mergers, and new product development and launches to strengthen type offerings as well as gain a competitive edge over others.
Bone Densitometer Industry News
- In February 2022, Aurora Spine partnered with Echolight Medical, the manufacturer of the radiation-free "EchoS portable densitometer" utilised to assess the quality of the software platform and the bone mineral density (BMD) in the patients affected. The two companies decided to advertise one other's products to their respective clients and prospects as part of the Aurora DEXA Platform. Such partnership helps the companies to accelerate its revenue growth.
This bone densitometer market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
Market, By Type
- Axial bone densitometry
- Dual energy X-ray absorptiometry (DEXA)
- Quantitative computed tomography (QCT)
- Peripheral bone densitometry
- Single energy X-ray absorptiometry (SEXA)
- Dual energy X-ray absorptiometry (pDEXA)
- Radiographic absorptiometry (RA)
- Quantitative ultrasound (QUS)
- Peripheral quantitative computed tomography (pQCT)
Market, By Application
- Osteoporosis and osteopenia diagnosis
- Cystic fibrosis diagnosis
- Chronic kidney diseases diagnosis
- Rheumatoid arthritis diagnosis
- Body composition measurement
Market, By End-use
- Hospital
- Specialty Clinics
- Others
The above information has been provided for the following regions and countries
- North America
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Israel